- Acquired by Ferring Pharmaceuticals for $80M, Jul 2005
About
Bio-Technology General (Israel) Ltd. (BTG) is an integrated biopharmaceutical company founded in 1980 by Professor Haim Aviv and colleagues from the Weizmann Institute of Science. It was established to leverage genetic engineering for developing and manufacturing human health care products. BTG is a pioneer in the development and manufacture of human health care products derived from genetic engineering and biotechnology processes. The company was acquired by Ferring Pharmaceuticals, a privately-held, multinational company headquartered in Switzerland, in 2005. Today, BTG operates as a Center for Excellence in Biotechnology for Ferring's Development and Manufacturing networks, with a focus on fertility and women's health, growth hormones, orthopedics and joint health, and contract development and manufacturing (CDMO) services.
Headcount over time
Offices
Q&A
- What is BTG's primary business?
- BTG (Bio-Technology General Israel) is an integrated biopharmaceutical services company that develops and manufactures healthcare products derived from genetic engineering and biotechnology processes.
- When was BTG founded?
- BTG was founded in September 1980.
- Which company acquired BTG and when?
- BTG was acquired by Ferring Pharmaceuticals in January 2005.
- What are some of BTG's key products?
- BTG's key products include Biolon, an injectable system for ophthalmic surgeries; Euflexxa, a treatment for osteoarthritis knee pain; and a recombinant human growth hormone for treating Turner syndrome and growth hormone deficiency.
- What was BTG's most recent funding round?
- BTG's most recent funding round occurred in May 2018, with Ferring Pharmaceuticals as an investor.
- What is the total amount of funding BTG has raised to date?
- BTG has raised a total of $26,930,000 USD.
- Who is the General Manager at BTG?
- Tal Levi is the General Manager at BTG.
Team · 13
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | btgil.com |
|---|---|
| linkedin.com/company/151809 | |
| facebook.com/btgil |
Identifiers & details
| Legal name | Bio-Technology General (Israel) Ltd. |
|---|---|
| Founded | 1980-10 |
| Employees (exact) | 420 |
| Status reason | Acquired by Ferring Pharmaceuticals on Jan, 2005 |
Acquisitions & public offerings
Acquired by Ferring Pharmaceuticals 2005-07 $80.0M
Radar intelligence
Patents
| EPO | 658 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | btgil.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 510861370 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1980-09-05 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 3 — annual_report (1), people (2) |
| Registered address | אזור התעשיה 0 קריית מלאכי |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-15 | דו~ח שנתי |
| 2026-06-15 | עדכון דירקטורים-הסרת דירקטור |
| 2026-06-15 | עדכון דירקטורים-הוספת דירקטור |